| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| SRTSSensus Healthcare, Inc. | 81.47M | 4.96 | 12.10 | 71.31% | -8.44% | -5.87% | 0.01 | |
| CATXPerspective Therapeutics, Inc. | 184.36M | 2.48 | -2.02 | -100% | -197.29% | -42.77% | 0.01 | |
| TLSITriSalus Life Sciences, Inc. | 307.28M | 6.15 | -4.92 | 58.99% | -98.45% | |||
| PROFProfound Medical Corp. | 302.68M | 8.34 | -7.79 | 41.23% | -272.77% | -130.59% | 0.08 | |
| DCTHDelcath Systems, Inc. | 354.29M | 10.21 | -11.03 | 17.02% | 1.5% | 1.04% | 0.02 | |
| PTHLPheton Holdings Ltd Class A Ordinary Shares | 8.46M | 0.90 | -17.38 | -28.7% | -91.16% | -13.91% | 0.04 | |
| ARAYAccuray Incorporated | 98.61M | 0.87 | -56.13 | 2.68% | -4.28% | -31.22% | 2.17 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 1.75M | 1.99M | 2.71M | 3.41M | 1.58M | 1.65M | 3.56M | 2.72M | 2.06M | 37.2M |
| Revenue Growth % | 0.63% | 0.14% | 0.36% | 0.25% | -0.54% | 0.04% | 1.16% | -0.24% | -0.24% | 17.02% |
| Cost of Goods Sold | 462K | 550K | 701K | 1.01M | 719K | 640K | 671K | 686K | 635K | 6.19M |
| COGS % of Revenue | 0.26% | 0.28% | 0.26% | 0.3% | 0.46% | 0.39% | 0.19% | 0.25% | 0.31% | 0.17% |
| Gross Profit | 1.28M | 1.44M | 2.01M | 2.4M | 861K | 1.01M | 2.88M | 2.03M | 1.43M | 31.02M |
| Gross Margin % | 0.74% | 0.72% | 0.74% | 0.7% | 0.54% | 0.61% | 0.81% | 0.75% | 0.69% | 0.83% |
| Gross Profit Growth % | 0.65% | 0.12% | 0.4% | 0.19% | -0.64% | 0.17% | 1.87% | -0.3% | -0.3% | 20.69% |
| Operating Expenses | 16.5M | 17.88M | 20.18M | 29.47M | 20.77M | 22.31M | 27.41M | 35.89M | 39.61M | 43.43M |
| OpEx % of Revenue | 9.44% | 8.98% | 7.43% | 8.65% | 13.14% | 13.55% | 7.71% | 13.2% | 19.18% | 1.17% |
| Selling, General & Admin | 10.01M | 9.43M | 9.68M | 9.82M | 11.28M | 11.11M | 13.64M | 17.3M | 22.11M | 29.55M |
| SG&A % of Revenue | 5.73% | 4.74% | 3.57% | 2.88% | 7.14% | 6.75% | 3.84% | 6.36% | 10.71% | 0.79% |
| Research & Development | 6.49M | 8.45M | 10.49M | 19.65M | 9.49M | 11.2M | 13.78M | 18.58M | 17.5M | 13.87M |
| R&D % of Revenue | 3.71% | 4.24% | 3.87% | 5.77% | 6.01% | 6.8% | 3.88% | 6.83% | 8.48% | 0.37% |
| Other Operating Expenses | -67K | 0 | -41K | 51K | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.21M | -16.44M | -18.16M | -27.07M | -19.91M | -21.3M | -24.53M | -33.85M | -38.18M | -12.41M |
| Operating Margin % | -8.71% | -8.25% | -6.69% | -7.95% | -12.6% | -12.94% | -6.9% | -12.45% | -18.49% | -0.33% |
| Operating Income Growth % | 0.21% | -0.08% | -0.1% | -0.49% | 0.26% | -0.07% | -0.15% | -0.38% | -0.13% | 0.67% |
| EBITDA | -14.59M | -16.14M | -17.86M | -26.63M | -19.66M | -21.14M | -24.39M | -33.72M | -37.78M | -12.18M |
| EBITDA Margin % | -8.35% | -8.1% | -6.58% | -7.82% | -12.44% | -12.84% | -6.86% | -12.4% | -18.3% | -0.33% |
| EBITDA Growth % | 0.2% | -0.11% | -0.11% | -0.49% | 0.26% | -0.08% | -0.15% | -0.38% | -0.12% | 0.68% |
| D&A (Non-Cash Add-back) | 617K | 305K | 310K | 444K | 249K | 167K | 146K | 132K | 399K | 229K |
| EBIT | -14.7M | -3.64M | -23.41M | -11.26M | -4.13M | -23.98M | -24.46M | -33.82M | -38.18M | -12.41M |
| Net Interest Income | -67K | -14.33M | -21.7M | -7.96M | -4.75M | -175K | -1.19M | -2.69M | -1.44M | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 67K | 14.33M | 21.7M | 7.96M | 4.75M | 175K | 1.19M | 2.69M | 1.44M | 0 |
| Other Income/Expense | 506K | -1.53M | -26.95M | 7.85M | 11.03M | -2.85M | -1.12M | -2.65M | -9.5M | -13.98M |
| Pretax Income | -14.7M | -17.97M | -45.12M | -19.22M | -8.88M | -24.16M | -25.65M | -36.51M | -47.68M | -26.39M |
| Pretax Margin % | -8.42% | -9.02% | -16.62% | -5.64% | -5.62% | -14.68% | -7.21% | -13.43% | -23.09% | -0.71% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% |
| Net Income | -14.7M | -17.97M | -45.12M | -19.22M | -8.88M | -24.16M | -25.65M | -36.51M | -47.68M | -26.39M |
| Net Margin % | -8.42% | -9.02% | -16.62% | -5.64% | -5.62% | -14.68% | -7.21% | -13.43% | -23.09% | -0.71% |
| Net Income Growth % | 0.15% | -0.22% | -1.51% | 0.57% | 0.54% | -1.72% | -0.06% | -0.42% | -0.31% | 0.45% |
| Net Income (Continuing) | -14.7M | -17.97M | -45.12M | -19.22M | -8.88M | -24.16M | -25.65M | -36.51M | -47.68M | -26.39M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -999999.00 | -999999.00 | -999999.00 | -503.85 | -342.82 | -8.35 | -3.59 | -4.12 | -2.94 | -0.93 |
| EPS Growth % | 0.51% | 0.27% | 1% | 1% | 0.32% | 0.98% | 0.57% | -0.15% | 0.29% | 0.68% |
| EPS (Basic) | -999999.00 | -999999.00 | -999999.00 | -503.85 | -342.82 | -8.35 | -3.59 | -4.12 | -2.94 | -0.93 |
| Diluted Shares Outstanding | 0 | 0 | 20 | 38.15K | 25.9K | 2.9M | 7.15M | 8.86M | 16.23M | 28.51M |
| Basic Shares Outstanding | 0 | 0 | 20 | 38.15K | 25.9K | 2.9M | 7.15M | 8.86M | 16.23M | 28.51M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 14.6M | 34.16M | 7.59M | 5.92M | 12.62M | 32.34M | 31.15M | 16.16M | 37.16M | 73.76M |
| Cash & Short-Term Investments | 12.61M | 4.41M | 4M | 2.52M | 10M | 28.57M | 22.8M | 7.67M | 32.45M | 53.23M |
| Cash Only | 12.61M | 4.41M | 4M | 2.52M | 10M | 28.57M | 22.8M | 7.67M | 12.65M | 32.41M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19.81M | 20.82M |
| Accounts Receivable | 277K | 403K | 317K | 1.16M | 21K | 57K | 44K | 366K | 483K | 11.06M |
| Days Sales Outstanding | 57.87 | 73.84 | 42.62 | 124.7 | 4.85 | 12.64 | 4.52 | 49.13 | 85.37 | 108.5 |
| Inventory | 757K | 660K | 1.25M | 858K | 654K | 855K | 1.41M | 2M | 3.32M | 6.93M |
| Days Inventory Outstanding | 598.06 | 438 | 649.81 | 310.38 | 332 | 487.62 | 768.08 | 1.06K | 1.91K | 408.94 |
| Other Current Assets | 960K | 28.04M | 1.47M | 1.19M | 626K | 509K | 4.36M | 4.25M | 387K | 1.39M |
| Total Non-Current Assets | 1.13M | 1.08M | 1.3M | 925K | 1.59M | 2.3M | 1.97M | 1.71M | 1.46M | 2.83M |
| Property, Plant & Equipment | 1.13M | 1.08M | 1.3M | 925K | 1.59M | 2.3M | 1.97M | 1.71M | 1.46M | 2.83M |
| Fixed Asset Turnover | 1.54x | 1.84x | 2.09x | 3.68x | 0.99x | 0.72x | 1.80x | 1.59x | 1.42x | 13.15x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 15.73M | 35.24M | 8.89M | 6.84M | 14.21M | 34.63M | 33.12M | 17.86M | 38.61M | 76.59M |
| Asset Turnover | 0.11x | 0.06x | 0.31x | 0.50x | 0.11x | 0.05x | 0.11x | 0.15x | 0.05x | 0.49x |
| Asset Growth % | -0.34% | 1.24% | -0.75% | -0.23% | 1.08% | 1.44% | -0.04% | -0.46% | 1.16% | 0.98% |
| Total Current Liabilities | 6.31M | 36.09M | 7.81M | 17.75M | 15.99M | 10.04M | 5.95M | 14.73M | 16.45M | 6.14M |
| Accounts Payable | 284K | 594K | 3.85M | 7.71M | 4.53M | 1.77M | 638K | 2.02M | 1.01M | 961K |
| Days Payables Outstanding | 224.37 | 394.2 | 2K | 2.79K | 2.3K | 1.01K | 347.05 | 1.07K | 581.7 | 56.68 |
| Short-Term Debt | 0 | 13.34M | 0 | 2.04M | 0 | 2M | 621K | 7.85M | 10.15M | 0 |
| Deferred Revenue (Current) | 0 | 30K | 0 | 1000K | 482K | 525K | 170K | 0 | 0 | 0 |
| Other Current Liabilities | 5.34M | 21.23M | 2.84M | 6.21M | 9.39M | 4.3M | 2.41M | 1.04M | 1.93M | 3.71M |
| Current Ratio | 2.31x | 0.95x | 0.97x | 0.33x | 0.79x | 3.22x | 5.23x | 1.10x | 2.26x | 12.01x |
| Quick Ratio | 2.19x | 0.93x | 0.81x | 0.29x | 0.75x | 3.14x | 4.99x | 0.96x | 2.06x | 10.88x |
| Cash Conversion Cycle | 431.56 | 117.64 | -1.31K | -2.36K | -1.96K | -511.48 | 425.55 | 38.49 | 1.41K | 460.76 |
| Total Non-Current Liabilities | 820K | 634K | 395K | 4.03M | 4.58M | 2.52M | 15.22M | 8.99M | 6.39M | 1.7M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 2M | 0 | 15.01M | 7.84M | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 197K | 450K | 207K | 0 | 0 | 933K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 820K | 604K | 395K | 628K | 0 | 0 | 0 | 1.14M | 6.39M | 766K |
| Total Liabilities | 7.13M | 36.73M | 8.21M | 21.78M | 20.57M | 12.56M | 21.17M | 23.72M | 22.84M | 7.84M |
| Total Debt | 0 | 13.34M | 0 | 2.04M | 2.86M | 2.94M | 16.25M | 15.87M | 10.19M | 1.04M |
| Net Debt | -12.61M | 8.93M | -4M | -478K | -7.14M | -25.63M | -6.55M | 8.2M | -2.46M | -31.37M |
| Debt / Equity | - | - | - | - | - | 0.13x | 1.36x | - | 0.65x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -227.01x | -1.15x | -0.84x | -3.40x | -4.19x | -121.73x | -20.68x | -12.61x | -26.53x | - |
| Total Equity | 8.6M | -1.49M | 678K | -14.94M | -6.36M | 22.08M | 11.95M | -5.86M | 15.78M | 68.75M |
| Equity Growth % | -0.53% | -1.17% | 1.46% | -23.03% | 0.57% | 4.47% | -0.46% | -1.49% | 3.69% | 3.36% |
| Book Value per Share | 0.40 | -0.36 | 33772.94 | -391.59 | -245.44 | 7.62 | 1.67 | -0.66 | 0.97 | 2.41 |
| Total Shareholders' Equity | 8.6M | -1.49M | 678K | -14.94M | -6.36M | 22.08M | 11.95M | -5.86M | 15.78M | 68.75M |
| Common Stock | 223K | 41K | 1.14M | 103K | 1K | 60K | 79K | 100K | 228K | 331K |
| Retained Earnings | -261.22M | -279.19M | -324.83M | -344.05M | -371.17M | -395.33M | -420.98M | -457.48M | -505.16M | -531.55M |
| Treasury Stock | -51K | -51K | -51K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -8K | -41K | 42K | 50K | 28K | -104K | 18K | -83K | 135K | 82K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -16.42M | -14.21M | -15.4M | -14.73M | -23.69M | -22.87M | -22.6M | -24.95M | -31.25M | -18.68M |
| Operating CF Margin % | -9.4% | -7.14% | -5.67% | -4.32% | -14.99% | -13.89% | -6.36% | -9.18% | -15.13% | -0.5% |
| Operating CF Growth % | -0.06% | 0.13% | -0.08% | 0.04% | -0.61% | 0.03% | 0.01% | -0.1% | -0.25% | 0.4% |
| Net Income | -14.7M | -17.97M | -45.12M | -19.22M | -8.88M | -24.16M | -25.65M | -36.51M | -47.68M | -26.39M |
| Depreciation & Amortization | 617K | 305K | 310K | 444K | 249K | 192K | 146K | 132K | 128K | 229K |
| Stock-Based Compensation | 657K | 427K | 129K | 58K | 277K | 3.91M | 7.83M | 7.94M | 8.15M | 9.77M |
| Deferred Taxes | 15K | 1K | 5.23M | -15.76M | 0 | 2.83M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -565K | 1.49M | 21.54M | 7.97M | -9.77M | 159K | 831K | 1.37M | 9.05M | 13.23M |
| Working Capital Changes | -2.44M | 1.54M | 2.51M | 11.77M | -5.56M | -5.81M | -5.76M | 2.11M | -906K | -15.52M |
| Change in Receivables | -52K | -138K | 108K | -293K | 497K | -36K | 13K | -322K | 125K | -10.65M |
| Change in Inventory | -420K | 95K | -543K | 385K | 204K | -201K | -557K | -587K | -1.32M | -3.61M |
| Change in Payables | -1.76M | 1.51M | 3.18M | 8.18M | -4.79M | -5.31M | -1.14M | 1.8M | -199K | 479K |
| Cash from Investing | 10K | -1.34M | -524K | -76K | -24K | -782K | -143K | -209K | -19.71M | -981K |
| Capital Expenditures | -170K | -258K | -524K | -76K | -24K | -782K | -143K | -209K | -58K | -559K |
| CapEx % of Revenue | 0.1% | 0.13% | 0.19% | 0.02% | 0.02% | 0.48% | 0.04% | 0.08% | 0.03% | 0.02% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 180K | -1.09M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 8.65M | 7.41M | 15.45M | 13.24M | 30.3M | 42.35M | 20.82M | 10.14M | 51.78M | 39.41M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | -527K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 0 | -26.2M | 2.85M | 12.44M | 0 | 2.62M | 2.46M | 0 | 35.01M | 43M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -16.59M | -14.47M | -15.92M | -14.81M | -23.71M | -23.65M | -22.75M | -25.16M | -31.31M | -19.24M |
| FCF Margin % | -9.5% | -7.26% | -5.86% | -4.35% | -15.01% | -14.37% | -6.4% | -9.25% | -15.16% | -0.52% |
| FCF Growth % | -0.06% | 0.13% | -0.1% | 0.07% | -0.6% | 0% | 0.04% | -0.11% | -0.24% | 0.39% |
| FCF per Share | -0.76 | -3.52 | -793116.15 | -388.15 | -915.56 | -8.16 | -3.18 | -2.84 | -1.93 | -0.67 |
| FCF Conversion (FCF/Net Income) | 1.12x | 0.79x | 0.34x | 0.77x | 2.67x | 0.95x | 0.88x | 0.68x | 0.66x | 0.71x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -109.95% | -505.44% | -6654.42% | - | - | -307.31% | -150.74% | -1198.36% | -961.44% | -62.44% |
| Return on Invested Capital (ROIC) | - | -717.28% | -660.87% | - | - | - | -1985.78% | -655.3% | -365.68% | -36.72% |
| Gross Margin | 73.55% | 72.39% | 74.18% | 70.38% | 54.49% | 61.12% | 81.13% | 74.77% | 69.25% | 83.37% |
| Net Margin | -841.67% | -902.16% | -1661.77% | -564.19% | -561.96% | -1467.56% | -721.49% | -1342.7% | -2308.86% | -70.92% |
| Debt / Equity | - | - | - | - | - | 0.13x | 1.36x | - | 0.65x | 0.02x |
| Interest Coverage | -227.01x | -1.15x | -0.84x | -3.40x | -4.19x | -121.73x | -20.68x | -12.61x | -26.53x | - |
| FCF Conversion | 1.12x | 0.79x | 0.34x | 0.77x | 2.67x | 0.95x | 0.88x | 0.68x | 0.66x | 0.71x |
| Revenue Growth | 63.42% | 14.02% | 36.3% | 25.49% | -53.62% | 4.18% | 115.98% | -23.52% | -24.05% | 1701.69% |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Product | 3.38M | 1.1M | 1.16M | 1.3M | 2.55M | 2.06M |
| Product Growth | - | -67.41% | 5.00% | 12.46% | 96.00% | -18.96% |
| Product and Service, Other | - | - | - | 2.25M | 171K | - |
| Product and Service, Other Growth | - | - | - | - | -92.42% | - |
| Product And Service Other | 29K | 479K | 490K | - | - | - |
| Product And Service Other Growth | - | 1551.72% | 2.30% | - | - | - |
Delcath Systems, Inc. (DCTH) reported $79.6M in revenue for fiscal year 2024.
Delcath Systems, Inc. (DCTH) grew revenue by 1701.7% over the past year. This is strong growth.
Yes, Delcath Systems, Inc. (DCTH) is profitable, generating $1.2M in net income for fiscal year 2024 (-70.9% net margin).
Delcath Systems, Inc. (DCTH) has a return on equity (ROE) of -62.4%. Negative ROE indicates the company is unprofitable.
Delcath Systems, Inc. (DCTH) generated $12.0M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.